Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?

Abstract

With currently recommended vancomycin dosing the therapeutic target of AUC/MIC > 400 is achieved only by 25% of neonates. Appropriate PKPD targets and respective dosing regimens need to be defined in prospective clinical studies in this population.